Fingerprint
Dive into the research topics of 'Defining the optimal dose of rifapentine for pulmonary tuberculosis: Exposure–response relations from two phase II clinical trials'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Defining the optimal dose of rifapentine for pulmonary tuberculosis: Exposure–response relations from two phase II clinical trials
for the Tuberculosis Trials Consortium of the Centers for Disease Control and Prevention
Research output: Contribution to journal › Article › peer-review
37
Scopus
citations